Loading…
Loading grant details…
| Funder | Medical Research Council |
|---|---|
| Recipient Organization | Institute of Cancer Research |
| Country | United Kingdom |
| Start Date | Oct 06, 2024 |
| End Date | Oct 05, 2028 |
| Duration | 1,460 days |
| Number of Grantees | 2 |
| Roles | Student; Supervisor |
| Data Source | UKRI Gateway to Research |
| Grant ID | 2933546 |
Mitosis is controlled by the major mitotic kinase CDK1 and its regulatory partner, Cyclin B. There are two B-type cyclins in vertebrate cells: Cyclins B1 and B2. Cyclin B1 is essential but the role of Cyclin B2 is controversial.
In this project we will use CRISPR/Cas9 gene editing to provide a definitive answer to the question of what role Cyclin B2 has in cell division and genome stability.
Institute of Cancer Research
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant